1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Bone Cancer

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Bone Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chatterjee, S; Martin, SF; Williams, N1
Sato, T; Wang, L; Wang, Y; Yamagata, S; Yamagata, T1

Other Studies

2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Bone Cancer

ArticleYear
Lactosylceramide is required in apoptosis induced by N-Smase.
    Glycoconjugate journal, 2006, Volume: 23, Issue:3-4

    Topics: Apoptosis; Bone Neoplasms; Enzyme Inhibitors; Glucosyltransferases; Humans; Lactosylceramides; Morpholines; Multienzyme Complexes; Mutation; NADH, NADPH Oxidoreductases; NADPH Oxidases; Osteosarcoma; Reactive Oxygen Species; Signal Transduction; Sphingomyelin Phosphodiesterase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2006
Ganglioside GD1a suppresses TNFalpha expression via Pkn1 at the transcriptional level in mouse osteosarcoma-derived FBJ cells.
    Biochemical and biophysical research communications, 2008, Jun-27, Volume: 371, Issue:2

    Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulation; G(M1) Ganglioside; Gene Expression Regulation, Neoplastic; Matrix Metalloproteinase 9; Mice; Morpholines; Osteosarcoma; Protein Kinase C; RNA, Small Interfering; Transcription, Genetic; Tumor Necrosis Factor-alpha

2008